BET-IN-16
Product Specifications
UNSPSC Description
BET-IN-16 (Comp I) is a BET inhibitor. BET-IN-16 shows anticancer activity. BET-IN-16 inhibits prostate cancer cell growth, with IC50 values of 0.043 and 0.034 μM against LNCaP and 22Rv1 cells, respectively[1].
Target Antigen
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bet-in-16.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=C(C2=CN(C(C3=NC=CC=C3)(C)C4=NC=CC=C4)C5=C2N=CC(C6=C(C)ON=C6C)=C5)C=C1)O
Molecular Weight
515.56
References & Citations
[1]Ben Powell, et al. Combinational drug anticancer therapies. Patent, WO2022040512A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-150268/BET-IN-16-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-150268/
Clinical Information
No Development Reported
CAS Number
2089390-09-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6183207-01 0.1 mL
CD248 (CD248 Molecule, endosialin, CD164L1, MGC119478, MGC119479, TEM1) (HRP)
Ask
View Details MBS6183207-02 5x 0.1 mL
CD248 (CD248 Molecule, endosialin, CD164L1, MGC119478, MGC119479, TEM1) (HRP)
Ask
View Details